Tag: pharmaceuticals
-
Lilly Licensing Autoimmune Therapy in $400M Deal
Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system.
-
Calif. Agency Supporting Late Stem Cell Trial for ALS
California’s agency supporting stem cell research for regenerative medicine is helping fund a clinical trial testing stem cell treatments for amyotrophic lateral sclerosis, or ALS.
-
Stem Cell Clinics Found Marketing in ClinicalTrials.gov
A review of entries in the U.S. government’s clinical trial registry shows commercial stem cell clinics are using the respected database to promote their services.
-
Biotech Licensing Viral T-Cell Immunotherapies
A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine.
-
FDA Grants Priority Review for Gene Therapy
A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder.
-
Arizona Medical Marijuana Operators Merge to Create Super Dispensary
Two of the biggest medical marijuana operators in Arizona – Modern Flower and Harvest – have merged to create a super dispensary.
-
America’s Overdose Epidemic In Perspective
This chart, from Statista, compares the rate of drug-induced deaths in the U.S. with other countries.
-
Start-Up Applying Artificial Intelligence to New Drug Uses
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs.
-
Report: Long, Complex Effort Needed to Stem Opioid Abuse
A report released today says years of coordinated public health efforts are needed at all levels to contain and reverse the current opioid abuse epidemic.
-
Nanotech Treatment Studied for Brain Tumors
Medical researchers and engineers designed and tested in mice a way to deliver gene-silencing therapies in nanoscale particles to treat glioblastoma, an aggressive form of brain cancer.